The authors found that the increased expression of PTTG in GH-secreting pituitary adenoma could explain tumoral migration and proliferation, suggesting that miR-423-5p could be used as a therapy in GH-secreting pituitary adenomas in the future. Here, PTTG1 is linked to pituitary gland adenoma.